1. Bluher M (2006) Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 55:908–914
2. Brunetti A, Manfioletti G, Chiefari E, Goldfine ID, Foti D (2001) Transcriptional regulation of human insulin receptor gene by the high-mobility group protein HMGI(Y). FASEB J 15:492–500
3. Chen W, Wang LL, Liu HY, Long L, Li S (2008) Peroxisome proliferator-activated receptor delta-agonist, GW501516, ameliorates insulin resistance, improves dyslipidaemia in monosodium l-glutamate metabolic syndrome mice. Basic Clin Pharmacol Toxicol 637:178–185
4. Chiefari E, Nevolo MT, Arcidiacono B, Maurizio E, Nocera A, Iiritano S, Sgarra R, Possidente K, Palmieri C, Paonessa F, Brunetti G, Manfioletti G, Foti D, Brunetti A (2012) HMGA1 is a novel downstream nuclear target of the insulin receptor signaling pathway. Sci Rep 251:1–10
5. Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z, Fezza F, Miura GI, Palmiter RD, Sugiura T, Kunos G (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410:822–825